Benign multi-cystic peritoneal mesothelioma of the porta hepatis.
Benign multi-cystic peritoneal mesothelioma of the porta hepatis
Journal
International journal of surgery case reports
ISSN: 2210-2612
Titre abrégé: Int J Surg Case Rep
Pays: Netherlands
ID NLM: 101529872
Informations de publication
Date de publication:
2020
2020
Historique:
received:
22
05
2020
revised:
23
08
2020
accepted:
24
08
2020
pubmed:
7
9
2020
medline:
7
9
2020
entrez:
6
9
2020
Statut:
ppublish
Résumé
Our case report describes a patient where multiple laparoscopies five years from initial presentation of symptoms were performed prior to laparotomy for benign multi-cystic peritoneal mesothelioma (BMPM), which has not been documented. A 61-year-old woman presented with years of chronic abdominal pain. Computerized tomography (CT) demonstrated a multi-cystic mass near the porta hepatis, and ultrasound was concerning for contained gallbladder perforation. Fine needle aspiration (FNA) demonstrated benign ductal epithelial cells in a background of mucin and bile without the presence of malignant cells. During laparotomy, a cystic mass attached to the porta hepatis seen emanating from the small bowel mesentery, and additional small cystic lesions through the abdomen were removed. The specimen, measuring 26 × 18 × 8 cm, showed multi-loculated cysts filled with serous fluid. BMPM is a rare neoplasm of mesothelioma cells originating from serosa of viscous organs. BMPMs appear as cystic structures with thin walls containing mucinous/gelatinous fluid. Microscopic features include a lack of invasion and no increased cellularity in the stroma, with or without inflammation (Myers & Babiker, 2018). It is postulated to be either a reactive or neoplastic process. There is no gold-standard treatment for BMPM. Our case is unique in the sense that our patient required several surgical biopsies before final diagnosis could be made. This case highlights the difficulty of diagnosing BMPM and differentiating it from malignant diseases that can present similarly and can be associated with significantly worse prognosis. Defined management strategies have yet to be demonstrated.
Identifiants
pubmed: 32892123
pii: S2210-2612(20)30647-7
doi: 10.1016/j.ijscr.2020.08.047
pmc: PMC7481495
pii:
doi:
Types de publication
Case Reports
Langues
eng
Pagination
218-221Informations de copyright
Copyright © 2020 The Authors. Published by Elsevier Ltd.. All rights reserved.
Références
Pol J Pathol. 2011;62(2):122-4
pubmed: 21866473
Cancer. 1979 Aug;44(2):692-8
pubmed: 476578
World J Emerg Surg. 2013 Oct 13;8(1):43
pubmed: 24120115
Int J Surg. 2018 Dec;60:132-136
pubmed: 30342279
Hum Pathol. 2003 Apr;34(4):369-74
pubmed: 12733118
Turk J Gastroenterol. 2009 Jun;20(2):138-41
pubmed: 19530048
J Surg Oncol. 2002 Apr;79(4):243-51
pubmed: 11920782